My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 148

    1.

    PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.

    Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y.

    Diabetes. 2001 Sep;50(9):2094-9.PMID: 11522676 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization.

    Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O'Rahilly S, Savage DB, Chatterjee K, Weiss S, Larson PJ, Gottesdiener KM, Gertz BJ, Charron MJ, Scherer PE, Moller DE.

    Endocrinology. 2002 Mar;143(3):998-1007.PMID: 11861525 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes.

    Gustafson B, Jack MM, Cushman SW, Smith U.

    Biochem Biophys Res Commun. 2003 Sep 5;308(4):933-9.PMID: 12927809 [PubMed - indexed for MEDLINE]Related articles

    4.

    Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.

    Peraldi P, Xu M, Spiegelman BM.

    J Clin Invest. 1997 Oct 1;100(7):1863-9.PMID: 9312188 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.

    Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM.

    Diabetes. 2002 Oct;51(10):2968-74.PMID: 12351435 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes.

    Kim KY, Kim JK, Jeon JH, Yoon SR, Choi I, Yang Y.

    Biochem Biophys Res Commun. 2005 Feb 11;327(2):460-7.PMID: 15629137 [PubMed - indexed for MEDLINE]Related articles

    7.

    Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

    Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T.

    J Clin Invest. 1998 Mar 15;101(6):1354-61.PMID: 9502777 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes.

    Smith U, Gogg S, Johansson A, Olausson T, Rotter V, Svalstedt B.

    FASEB J. 2001 Jan;15(1):215-220.PMID: 11149909 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The effect of PPARgamma ligands on the adipose tissue in insulin resistance.

    Hammarstedt A, Andersson CX, Rotter Sopasakis V, Smith U.

    Prostaglandins Leukot Essent Fatty Acids. 2005 Jul;73(1):65-75. Review.PMID: 15936183 [PubMed - indexed for MEDLINE]Related articles

    10.

    Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.

    Berger J, Tanen M, Elbrecht A, Hermanowski-Vosatka A, Moller DE, Wright SD, Thieringer R.

    J Biol Chem. 2001 Apr 20;276(16):12629-35. Epub 2001 Jan 22.PMID: 11278270 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice.

    Moore GB, Chapman H, Holder JC, Lister CA, Piercy V, Smith SA, Clapham JC.

    Biochem Biophys Res Commun. 2001 Aug 31;286(4):735-41.PMID: 11520059 [PubMed - indexed for MEDLINE]Related articles

    12.

    Brown adipocytes are novel sites of expression and regulation of adiponectin and resistin.

    Viengchareun S, Zennaro MC, Pascual-Le Tallec L, Lombes M.

    FEBS Lett. 2002 Dec 18;532(3):345-50.PMID: 12482590 [PubMed - indexed for MEDLINE]Related articles

    13.

    Adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression.

    Seo JB, Moon HM, Noh MJ, Lee YS, Jeong HW, Yoo EJ, Kim WS, Park J, Youn BS, Kim JW, Park SD, Kim JB.

    J Biol Chem. 2004 May 21;279(21):22108-17. Epub 2004 Mar 22.PMID: 15037635 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.

    Kanatani Y, Usui I, Ishizuka K, Bukhari A, Fujisaka S, Urakaze M, Haruta T, Kishimoto T, Naka T, Kobayashi M.

    Diabetes. 2007 Mar;56(3):795-803.PMID: 17327450 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects.

    Rotter V, Nagaev I, Smith U.

    J Biol Chem. 2003 Nov 14;278(46):45777-84. Epub 2003 Sep 2.PMID: 12952969 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The role of the novel adipocyte-derived hormone adiponectin in human disease.

    Díez JJ, Iglesias P.

    Eur J Endocrinol. 2003 Mar;148(3):293-300. Review.PMID: 12611609 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes.

    Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R.

    Biochem Biophys Res Commun. 2002 Jan 25;290(3):1084-9.PMID: 11798186 [PubMed - indexed for MEDLINE]Related articles

    18.

    Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice.

    Delporte ML, El Mkadem SA, Quisquater M, Brichard SM.

    Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E446-53. Epub 2004 May 4.PMID: 15126241 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones.

    Tanaka T, Itoh H, Doi K, Fukunaga Y, Hosoda K, Shintani M, Yamashita J, Chun TH, Inoue M, Masatsugu K, Sawada N, Saito T, Inoue G, Nishimura H, Yoshimasa Y, Nakao K.

    Diabetologia. 1999 Jun;42(6):702-10.PMID: 10382590 [PubMed - indexed for MEDLINE]Related articles

    20.

    Identification of regulatory elements in the human adipose most abundant gene transcript-1 ( apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways.

    Barth N, Langmann T, Schölmerich J, Schmitz G, Schäffler A.

    Diabetologia. 2002 Oct;45(10):1425-33. Epub 2002 Jul 4. Erratum in: Diabetologia. 2004 Jan;47(1):153. PMID: 12378384 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity